BACKGROUND: Heart failure (HF) is a clinical syndrome characterized by signs and symptoms involving multiple organ systems. Longitudinal data demonstrating that asymptomatic cardiac dysfunction precedes overt HF are scarce, and the contribution of noncardiac dysfunction to HF progression is unclear. We hypothesized that subclinical cardiac and noncardiac organ dysfunction would accelerate the manifestation of HF. METHODS AND RESULTS: We studied 1038 participants of the Framingham Heart Study original cohort (mean age, 76±5 years; 39% men) with routine assessment of left ventricular systolic and diastolic function. Major noncardiac organ systems were assessed with the use of serum creatinine (renal), serum albumin (hepatic), ratio of forced expiratory volume in 1 second to forced vital capacity (FEV(1):FVC ratio; pulmonary), hemoglobin concentration (hematologic/oxygen-carrying capacity), and white blood cell count (systemic inflammation). On follow-up (mean, 11 years), there were 248 incident HF events (146 in women). After adjustment for established HF risk factors, antecedent left ventricular systolic dysfunction (hazard ratio, 2.33; 95% confidence interval, 1.43 to 3.78) and diastolic dysfunction (hazard ratio, 1.32; 95% confidence interval, 1.01 to 1.71) were associated with increased HF risk. After adjustment for cardiac dysfunction, higher serum creatinine, lower FEV1:FVC ratios, and lower hemoglobin concentrations were associated with increased HF risk (all P<0.05); serum albumin and white blood cell count were not. Subclinical dysfunction in each noncardiac organ system was associated with a 30% increased risk of HF (P=0.013). CONCLUSIONS: Antecedent cardiac dysfunction and noncardiac organ dysfunction are associated with increased incidence of HF, supporting the notion that HF is a progressive syndrome and underscoring the importance of noncardiac factors in its occurrence.
BACKGROUND:Heart failure (HF) is a clinical syndrome characterized by signs and symptoms involving multiple organ systems. Longitudinal data demonstrating that asymptomatic cardiac dysfunction precedes overt HF are scarce, and the contribution of noncardiac dysfunction to HF progression is unclear. We hypothesized that subclinical cardiac and noncardiac organ dysfunction would accelerate the manifestation of HF. METHODS AND RESULTS: We studied 1038 participants of the Framingham Heart Study original cohort (mean age, 76±5 years; 39% men) with routine assessment of left ventricular systolic and diastolic function. Major noncardiac organ systems were assessed with the use of serum creatinine (renal), serum albumin (hepatic), ratio of forced expiratory volume in 1 second to forced vital capacity (FEV(1):FVC ratio; pulmonary), hemoglobin concentration (hematologic/oxygen-carrying capacity), and white blood cell count (systemic inflammation). On follow-up (mean, 11 years), there were 248 incident HF events (146 in women). After adjustment for established HF risk factors, antecedent left ventricular systolic dysfunction (hazard ratio, 2.33; 95% confidence interval, 1.43 to 3.78) and diastolic dysfunction (hazard ratio, 1.32; 95% confidence interval, 1.01 to 1.71) were associated with increased HF risk. After adjustment for cardiac dysfunction, higher serum creatinine, lower FEV1:FVC ratios, and lower hemoglobin concentrations were associated with increased HF risk (all P<0.05); serum albumin and white blood cell count were not. Subclinical dysfunction in each noncardiac organ system was associated with a 30% increased risk of HF (P=0.013). CONCLUSIONS: Antecedent cardiac dysfunction and noncardiac organ dysfunction are associated with increased incidence of HF, supporting the notion that HF is a progressive syndrome and underscoring the importance of noncardiac factors in its occurrence.
Authors: Daniel D Correa de Sa; David O Hodge; Joshua P Slusser; Magaret M Redfield; Robert D Simari; John C Burnett; Horng H Chen Journal: Heart Date: 2010-04 Impact factor: 5.994
Authors: M Fischer; A Baessler; H W Hense; C Hengstenberg; M Muscholl; S Holmer; A Döring; U Broeckel; G Riegger; H Schunkert Journal: Eur Heart J Date: 2003-02 Impact factor: 29.983
Authors: Javed Butler; Andreas Kalogeropoulos; Vasiliki Georgiopoulou; Rhonda Belue; Nicolas Rodondi; Melissa Garcia; Douglas C Bauer; Suzanne Satterfield; Andrew L Smith; Viola Vaccarino; Anne B Newman; Tamara B Harris; Peter W F Wilson; Stephen B Kritchevsky Journal: Circ Heart Fail Date: 2008-07 Impact factor: 8.790
Authors: R Graham Barr; David A Bluemke; Firas S Ahmed; J Jeffery Carr; Paul L Enright; Eric A Hoffman; Rui Jiang; Steven M Kawut; Richard A Kronmal; João A C Lima; Eyal Shahar; Lewis J Smith; Karol E Watson Journal: N Engl J Med Date: 2010-01-21 Impact factor: 91.245
Authors: Jithendra B Somaratne; Colin Berry; John J V McMurray; Katrina K Poppe; Robert N Doughty; Gillian A Whalley Journal: Eur J Heart Fail Date: 2009-08-04 Impact factor: 15.534
Authors: Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer Journal: JAMA Date: 2003-01-08 Impact factor: 56.272
Authors: Ramachandran S Vasan; Emelia J Benjamin; Martin G Larson; Eric P Leip; Thomas J Wang; Peter W F Wilson; Daniel Levy Journal: JAMA Date: 2002-09-11 Impact factor: 56.272
Authors: Danielle M Henkel; Margaret M Redfield; Susan A Weston; Yariv Gerber; Véronique L Roger Journal: Circ Heart Fail Date: 2008-07 Impact factor: 8.790
Authors: J Woo; X Yang; L Tin Lui; Q Li; K Fai Cheng; Y Fan; F Yau; A P W Lee; J S W Lee; E Fung Journal: J Nutr Health Aging Date: 2019 Impact factor: 4.075
Authors: Wael A AlJaroudi; M Chadi Alraies; Carmel Halley; Venu Menon; L Leonardo Rodriguez; Richard A Grimm; James D Thomas; Wael A Jaber Journal: Int J Cardiovasc Imaging Date: 2013-07-11 Impact factor: 2.357
Authors: Sanjiv J Shah; Dalane W Kitzman; Barry A Borlaug; Loek van Heerebeek; Michael R Zile; David A Kass; Walter J Paulus Journal: Circulation Date: 2016-07-05 Impact factor: 29.690
Authors: Ambarish Pandey; Minesh Patel; Ang Gao; Benjamin L Willis; Sandeep R Das; David Leonard; Mark H Drazner; James A de Lemos; Laura DeFina; Jarett D Berry Journal: Am Heart J Date: 2014-11-12 Impact factor: 4.749
Authors: Stephanie K Brinker; Ambarish Pandey; Colby R Ayers; Carolyn E Barlow; Laura F DeFina; Benjamin L Willis; Nina B Radford; Ramin Farzaneh-Far; James A de Lemos; Mark H Drazner; Jarett D Berry Journal: JACC Heart Fail Date: 2014-04-30 Impact factor: 12.035
Authors: Ambarish Pandey; Neil Keshvani; Colby Ayers; Adolfo Correa; Mark H Drazner; Alana Lewis; Carlos J Rodriguez; Michael E Hall; Ervin R Fox; Robert J Mentz; Christopher deFilippi; Stephen L Seliger; Christie M Ballantyne; Ian J Neeland; James A de Lemos; Jarett D Berry Journal: JAMA Cardiol Date: 2019-01-01 Impact factor: 14.676